返回
Bone Biologics Corp（BBLG）價格
BBLG 股價走勢圖
BBLG 收益
Bone Biologics Corp
$1.78
6.58%
$0.11
收盤價：Jan 16, 16:00:00 GMT-5
$1.76
-1.12%
$-0.02
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$1.67
開盤價
$1.68
當日範圍
$1.67 - $1.88
52週區間
$1.3 - $7.74
交易量
142.8K
平均成交量
310.2K
每股盈餘 (TTM)
-7.30
股息收益率
--
市值
$3.1M
什麼是 BBLG？
Bone Biologics Corp. operates as a medical device company. The company is headquartered in Burlington, Massachusetts and currently employs 2 full-time employees. The company went IPO on 2015-11-27. The firm is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.